首页> 外文期刊>Neuropeptides: An International Journal >Central administration of angiotensin-(1-7) stimulates nitric oxide release and upregulates the endothelial nitric oxide synthase expression following focal cerebral ischemia/reperfusion in rats.
【24h】

Central administration of angiotensin-(1-7) stimulates nitric oxide release and upregulates the endothelial nitric oxide synthase expression following focal cerebral ischemia/reperfusion in rats.

机译:在大鼠局灶性脑缺血/再灌注后,中央给予血管紧张素-(1-7)刺激一氧化氮释放并上调内皮一氧化氮合酶的表达。

获取原文
获取原文并翻译 | 示例
       

摘要

Angiotensin-(1-7) [Ang-(1-7)] is an endogenous peptide of the renin-angiotensin system with several beneficial effects that are often opposite to those attributed to angiotensin II (Ang II). Since there are no data available so far on the role of Ang-(1-7) after cerebral ischemia/reperfusion, in this paper, we investigated the central administration of Ang-(1-7) modulates in vivo the nitric oxide(NO) release and the endothelial NO synthase (eNOS) expression following focal cerebral ischemia/reperfusion in rats. Cerebral ischemia-reperfusion injury was induced by intraluminal thread occlusion of middle cerebral artery in the adult male rats. The levels of NO in ischemic tissues were measured by NO detection kits. Reverse transcription (RT)-PCR and western blot were used to determine messenger RNA (mRNA) and protein levels of the eNOS in ischemic tissues. The cerebral ischemic lesion resulted in a significant increase of NO release at 3 and 6h compared with sham operation group in our model after reperfusion, whereas both medium and high doses Ang-(1-7) markedly enhanced NO levels at 3-24h, and 3-72h after reperfusion, respectively. In addition, NO release increased was significantly induced by high-dose Ang-(1-7) compared with medium-dose Ang-(1-7) at 24-72h after reperfusion. Medium and high-dose Ang-(1-7) significantly stimulated eNOS activation when compared with artificial cerebrospinal fluid (aCSF) treatment group at 3, 6, 12, 24, and 48h after reperfusion, however, no significant changes in eNOS expression were found between medium and high-dose Ang-(1-7) at different times after the ischemic insult. These findings indicate that medium and high-dose Ang-(1-7) stimulate NO release and upregulate eNOS expression in ischemic tissues following focal cerebral ischemia/reperfusion in rats.
机译:血管紧张素-(1-7)[Ang-(1-7)]是肾素-血管紧张素系统的内源性肽,具有多种有益作用,这些作用通常与归因于血管紧张素II(Ang II)的作用相反。由于到目前为止尚无关于Ang-(1-7)在脑缺血/再灌注后的作用的数据,因此在本文中,我们研究了Ang-(1-7)的中央给药在体内调节一氧化氮(NO大鼠局灶性脑缺血/再灌注后释放和内皮一氧化氮合酶(eNOS)表达。成年雄性大鼠大脑中动脉腔内螺纹闭塞引起脑缺血再灌注损伤。用NO检测试剂盒测量缺血组织中的NO水平。逆转录(RT)-PCR和蛋白质印迹用于确定缺血组织中eNOS的信使RNA(mRNA)和蛋白水平。与假手术组相比,在再灌注后,脑缺血病变导致3和6h时NO释放量显着增加,而中剂量和高剂量Ang-(1-7)均在3-24h时显着增强了NO的释放,并且再灌注后3-72h。另外,与中剂量Ang-(1-7)相比,高剂量Ang-(1-7)在再灌注后24-72h显着诱导NO释放增加。与再灌注后3、6、12、24和48h的人工脑脊髓液(aCSF)治疗组相比,中等剂量和大剂量Ang-(1-7)显着刺激了eNOS的激活,但是eNOS表达没有明显变化。在缺血性损伤后不同时间在中等剂量和大剂量Ang-(1-7)之间发现。这些发现表明,大鼠局灶性脑缺血/再灌注后,中等剂量和大剂量Ang-(1-7)刺激NO释放并上调缺血组织中的eNOS表达。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号